PDBsum entry 1xr9

Immune system/ligase

PDB id: 1xr9

Contents

Protein chains

276 a.a. *

99 a.a. *

Ligands

ILE-LEU-GLY-PRO-PRO-GLY-SER-VAL-TYR

SO4 ×2

URE

GOL

Waters ×595

* Residue conservation analysis

PDB id:

1xr9

Name:

Immune system/ligase

Title:

Crystal structures of hla-b 1501 In complex with peptides from human ubch6 and epstein-barr virus ebna-3

Structure:

Hla class i histocompatibility antigen, b-15 alpha chain. Chain: a. Fragment: residues 1-276. Synonym: mhc class i antigen b 15, Hla-b 1501. Engineered: yes. Beta-2-microglobulin. Chain: b. Synonym: hdcma22p. Engineered: yes.

Source:

Homo sapiens. Human. Organism_taxid: 9606. Gene: hla-bw62.1. Expressed in: escherichia coli bl21(de3). Expression_system_taxid: 469008. Gene: b2m. Synthetic: yes. Other_details: chemical synthesis

Biol. unit:

Trimer (from PQS)

Resolution:

1.79Å R-factor: 0.180 R-free: 0.232

Authors:

G.Roder,T.Blicher,B.R.Johannessen,O.Kristensen,S.Buus,M.Gajhede

Key ref:

G.Røder et al. (2006). Crystal structures of two peptide-HLA-B*1501 complexes; structural characterization of the HLA-B62 supertype. Acta Crystallogr D Biol Crystallogr, 62, 1300-1310. PubMed id: 17057332 DOI: 10.1107/S0907444906027636

Date:

14-Oct-04 Release date: 14-Apr-05

Protein chain

P01889  (1B07_HUMAN) -  HLA class I histocompatibility antigen, B alpha chain from Homo sapiens

Seq: 362 a.a.

Struc: 276 a.a.*

Protein chain

P61769  (B2MG_HUMAN) -  Beta-2-microglobulin from Homo sapiens

Seq: 119 a.a.

Struc: 99 a.a.

* PDB and UniProt seqs differ at 19 residue positions (black crosses)

Enzyme reactions

• Enzyme class: Chains : E.C.6.3.2.19 - Transferred entry: 2.3.2.23, 2.3.2.27 and 6.2.1.45.
• Reaction: ATP + ubiquitin + protein lysine = AMP + diphosphate + protein N-ubiquityllysine

Molecule diagrams generated from .mol files obtained from the KEGG ftp site

reference

DOI no: 10.1107/S0907444906027636

Acta Crystallogr D Biol Crystallogr 62:1300-1310 (2006)

PubMed id: 17057332

Crystal structures of two peptide-HLA-B*1501 complexes; structural characterization of the HLA-B62 supertype.

G.Røder, T.Blicher, S.Justesen, B.Johannesen, O.Kristensen, J.Kastrup, S.Buus, M.Gajhede.

ABSTRACT

MHC class I molecules govern human cytotoxic T cell responses. Their specificity determines which peptides they sample from the intracellular protein environment and then present to human cytotoxic T cells. More than 1100 different MHC class I proteins have been found in human populations and it would be a major undertaking to address each of these specificities individually. Based upon their peptide binding specificity, they are currently subdivided into 12 supertypes. Several of these HLA supertypes have not yet been described at the structural level. To support a comprehensive understanding of human immune responses, the structure of at least one member of each supertype should be determined. Here, the structures of two immunogenic peptide-HLA-B*1501 complexes are described. The structure of HLA-B*1501 in complex with a peptide (LEKARGSTY, corresponding to positions 274-282 in the Epstein-Barr virus nuclear antigen-3A) was determined to 2.3 A resolution. The structure of HLA-B*1501 in complex with a peptide (ILGPPGSVY) derived from human ubiquitin-conjugating enzyme-E2 corresponding to positions 91-99 was solved to 1.8 A resolution. Mutual comparisons of these two structures with structures from other HLA supertypes define and explain the specificity of the P2 and P9 peptide anchor preferences in the B62 HLA supertype. The P2 peptide residue binds to the B-pocket in HLA-B*1501. This pocket is relatively large because of the small Ser67 residue located at the bottom. The peptide proximal part of the B-pocket is hydrophobic, which is consistent with P2 anchor residue preference for Leu. The specificity of the B-pocket is determined by the Met45, Ile66 and Ser67 residues. The apex of the B-pocket is hydrophilic because of the Ser67 residue. The P9 peptide residue binds to the F-pocket in HLA-B*1501. The residues most important for the specificity of this pocket are Tyr74, Leu81, Leu95, Tyr123 and Trp147. These residues create a hydrophobic interior in the F-pocket and their spatial arrangement makes the pocket capable of containing large, bulky peptide side chains. Ser116 is located at the bottom of the F-pocket and makes the bottom of this pocket hydrophilic. Ser116, may act as a hydrogen-bonding partner and as such is a perfect place for binding of a Tyr9 peptide residue. Thus, based on structure information it is now possible to explain the peptide sequence specificity of HLA-B*1501 as previously determined by peptide binding and pool sequencing experiments.

Selected figure(s)

Figure 1.
Figure 1 ARP/wARP electron-density maps before manual inclusion of the (a) LEKARGSTY and (b) ILGPPGSVY peptides from the HLA-B*1501 complexes. The peptide N-termini are located at the left and one-letter amino-acid codes are used. The A-conformation of the ILGPPGSVY peptide is shown in red, while the B-conformation is shown in green. The electron densities are rendered at 1.0 level.

Figure 4.
Figure 4 Surface representations of (a) HLA-B*1501 (this work), (b) HLA-A*0201 (Khan et al., 2000[Khan, A. R., Baker, B. M., Ghosh, P., Biddison, W. E. & Wiley, D. C. (2000). J. Immunol. 164, 6398-6405.]) and (c) HLA-A*1101 (Blicher et al., 2005[Blicher, T., Kastrup, J. S., Buus, S. & Gajhede, M. (2005). Acta Cryst. D61, 1031-1040.]). The surfaces are colored by the standard convention for atoms.

The above figures are reprinted by permission from the IUCr: Acta Crystallogr D Biol Crystallogr (2006, 62, 1300-1310) copyright 2006.

Figures were selected by an automated process.